Keywords: |
protein expression; young adult; unclassified drug; genetics; cancer patient; protein function; cell cycle protein; metabolism; cell cycle proteins; gene expression; nuclear protein; transcription factor; in vivo study; antineoplastic activity; in vitro study; enzyme activity; transcription factors; nuclear proteins; methyltransferase; epigenetics; chromatin; epigenesis, genetic; transcription factor e2f; cancer cell; gene repression; carcinoma; cyclin dependent kinase inhibitor 2a; genetic epigenesis; anaplastic carcinoma; transcription factor ezh2; peptides and proteins; vulnerability; polycomb repressive complex 2; humans; human; article; bromodomain inhibitor; rb1 protein; nut carcinoma; brd4 protein, human; tazemetostat; malignant neoplasm; mivebresib
|